Table 3 Regression weights and standard errors for mixed model analyses predicting EMG in Acquisition and Extinction phases.

From: Transcutaneous vagus nerve stimulation and extinction of prepared fear: A conceptual non-replication

Predictor

Acquisition

Extinction

Intercept

57.03 (0.88)**

56.10 (0.80)**

CStypeCS−

−1.76 (1.25)

1.12 (1.12)

CStypeITI

−1.51 (1.25)

−4.41 (1.12)

Trial

−0.16 (0.21)

−1.24 (0.12)**

Trial*CStypeCS−

−1.45 (0.30)*

−0.09 (0.17)

Trial*CStypeITI

−0.58 (0.30)**

−0.07 (0.17)**

Condition

0.02 (1.26)

−0.47 (1.13)

Condition*CStypeCS−

0.61 (1.78)

−1.32 (1.60)

Condition*CStypeITI

0.27 (1.78)

−0.02 (1.59)

Condition*Trial

−0.37 (0.30)

0.13 (0.17)

Condition*Trial*CStypeCS−

0.64 (0.42)

0.03 (0.24)

Condition*Trial*CStypeITI

0.18 (0.42)

0.13 (0.24)

  1. Note. Reference category for CStype is the CS+ trial type. All analyses on the effects of tVNS were conducted using one-sided hypothesis tests. *p < 0.05, **p < 0.001.